• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

泪腺多形性腺瘤和恶性上皮肿瘤:临床和影像学差异。

Lacrimal gland pleomorphic adenoma and malignant epithelial tumours: clinical and imaging differences.

机构信息

Department of Ophthalmology, National University Hospital, Singapore.

Department of Ophthalmology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea

出版信息

Br J Ophthalmol. 2019 Feb;103(2):264-268. doi: 10.1136/bjophthalmol-2017-311538. Epub 2018 Apr 21.

DOI:10.1136/bjophthalmol-2017-311538
PMID:29680804
Abstract

AIMS

To investigate the clinical and imaging features of primary and recurrent lacrimal gland pleomorphic adenoma (LGPA), as well as lacrimal gland malignant epithelial tumours (LGMET).

METHODS

Retrospective comparative case series from September 2000 to September 2016 in a single tertiary institution. Medical records of cases with histopathologically proven primary LGPA (PLGPA), recurrent LGPA (RLGPA) and LGMET were reviewed.

RESULTS

Sixty-four patients with LGPA (55 primary and nine recurrent) and 36 patients with LGMET underwent surgical excision in the study period. There was no significant difference in terms of age, gender or laterality. In terms of symptom duration, that of LGMET (7.1 months) was significantly shorter than PLGPA (23.9 months), which in turn was significantly shorter than RLGPA (127.1 months). Proptosis was the most common presenting symptom among all three groups. On CT, LGMET and RLGPA were significantly more likely to have ill-defined margins (p<0.001) and be heterogeneous (p<0.001) than PLGPA. RLGPAs (56%) were significantly more likely to have calcification than LGMET (34%), which in turn was more likely to have calcification than PLGPA (13%); LGMET (40%) and RLGPA (33%) were significantly more likely to have bony invasion than PLGPA (2.2%). On MRI, LGMETs (55%) were significantly more likely to have a tail or wedge sign indicating infiltration into the posterior orbit than PLGPA (0%) or RLGPA (0%).

CONCLUSION

Our study adds important information regarding differentiating clinical and radiological features between malignant and benign epithelial lacrimal gland tumours that would aid in their management.

摘要

目的

探讨原发性和复发性泪腺多形性腺瘤(LGPA)以及泪腺恶性上皮肿瘤(LGMET)的临床和影像学特征。

方法

这是一项在 2000 年 9 月至 2016 年 9 月于一家三级医疗机构进行的回顾性对比病例系列研究。对经组织病理学证实为原发性 LGPA(PLGPA)、复发性 LGPA(RLGPA)和 LGMET 的病例的病历进行了回顾性分析。

结果

在研究期间,共有 64 例 LGPA(55 例原发性,9 例复发性)和 36 例 LGMET 患者接受了手术切除。三组患者的年龄、性别或侧别均无显著差异。在症状持续时间方面,LGMET(7.1 个月)明显短于 PLGPA(23.9 个月),而 PLGPA 又明显短于 RLGPA(127.1 个月)。突眼是三组患者最常见的首发症状。在 CT 上,LGMET 和 RLGPA 比 PLGPA 更有可能表现为边界不清(p<0.001)和不均匀(p<0.001)。RLGPA(56%)比 LGMET(34%)更易发生钙化,而 LGMET 又比 PLGPA(13%)更易发生钙化;LGMET(40%)和 RLGPA(33%)比 PLGPA(2.2%)更易发生骨质侵犯。在 MRI 上,LGMET(55%)比 PLGPA(0%)或 RLGPA(0%)更易出现提示向后眶浸润的“尾巴”或“楔形”征。

结论

本研究提供了有关区分良恶性上皮性泪腺肿瘤的临床和影像学特征的重要信息,有助于其治疗。

相似文献

1
Lacrimal gland pleomorphic adenoma and malignant epithelial tumours: clinical and imaging differences.泪腺多形性腺瘤和恶性上皮肿瘤:临床和影像学差异。
Br J Ophthalmol. 2019 Feb;103(2):264-268. doi: 10.1136/bjophthalmol-2017-311538. Epub 2018 Apr 21.
2
Recurrent lacrimal gland pleomorphic adenoma: clinical and computed tomography features.复发性泪腺多形性腺瘤:临床和 CT 特征。
Ophthalmology. 2011 Oct;118(10):2088-92. doi: 10.1016/j.ophtha.2011.03.014.
3
Atypical presentations of pleomorphic adenoma of the lacrimal gland.泪腺多形性腺瘤的非典型表现。
Ophthalmic Plast Reconstr Surg. 2007 Jul-Aug;23(4):272-4. doi: 10.1097/IOP.0b013e3180686e63.
4
Clinico-radiological features of primary lacrimal gland pleomorphic adenoma: an analysis of 37 cases.原发性泪腺多形性腺瘤的临床影像学特征:37例分析
Jpn J Ophthalmol. 2016 Jul;60(4):286-93. doi: 10.1007/s10384-016-0451-3. Epub 2016 May 16.
5
Retrospective Analysis of Clinicopathological Characteristics of Lacrimal Gland Pleomorphic Adenoma and Mechanism of Tumorigenesis by the Imbalance Between Apoptosis and Proliferation.泪腺多形性腺瘤临床病理特征及凋亡与增殖失衡致瘤机制的回顾性分析
Med Sci Monit. 2021 Mar 19;27:e929152. doi: 10.12659/MSM.929152.
6
Removal of recurrent intraorbital tumour using a system of augmented reality.使用增强现实系统切除复发性眶内肿瘤。
Br J Oral Maxillofac Surg. 2017 Nov;55(9):962-964. doi: 10.1016/j.bjoms.2017.08.360. Epub 2017 Sep 13.
7
Pleomorphic adenoma of the lacrimal gland in a nine-year-old child.一名9岁儿童的泪腺多形性腺瘤。
Clin Exp Ophthalmol. 2005 Dec;33(6):639-41. doi: 10.1111/j.1442-9071.2005.01112.x.
8
A case of mistaken identity: the role of lacrimal gland pleomorphic adenoma tissue diagnosis.一例身份误诊病例:泪腺多形性腺瘤的组织诊断作用
Int Ophthalmol. 2018 Feb;38(1):381-384. doi: 10.1007/s10792-017-0445-2. Epub 2017 Jan 21.
9
Pleomorphic adenoma of the lacrimal gland with extensive calcification.泪腺多形性腺瘤伴广泛钙化
Arch Ophthalmol. 2004 May;122(5):778-80. doi: 10.1001/archopht.122.5.778.
10
Pleomorphic adenoma of the lacrimal gland: is there a role for biopsy?泪腺多形性腺瘤:活检有作用吗?
Eye (Lond). 2009 Jan;23(1):2-6. doi: 10.1038/eye.2008.16. Epub 2008 Mar 7.

引用本文的文献

1
Incidence, clinical features, and survival outcomes of primary malignant lacrimal gland tumors: A population-based analysis.原发性泪腺恶性肿瘤的发病率、临床特征和生存结局:一项基于人群的分析。
Cancer Med. 2024 Feb;13(3):e6831. doi: 10.1002/cam4.6831. Epub 2024 Jan 17.
2
Advances in clinical examination of lacrimal gland.泪腺临床检查的进展
Front Med (Lausanne). 2023 Aug 31;10:1257209. doi: 10.3389/fmed.2023.1257209. eCollection 2023.
3
Orbital Tumors-Clinical, Radiologic and Histopathologic Correlation.眼眶肿瘤——临床、放射学与组织病理学的相关性
Diagnostics (Basel). 2022 Sep 30;12(10):2376. doi: 10.3390/diagnostics12102376.
4
Clinical and radiologic outcomes of pleomorphic adenoma and adenoid cystic carcinoma of the lacrimal gland.泪腺多形性腺瘤和腺样囊性癌的临床及影像学结果
Arq Bras Oftalmol. 2023 Jul-Aug;86(4):359-364. doi: 10.5935/0004-2749.20230056.
5
Masses of the Lacrimal Gland: Evaluation and Treatment.泪腺肿物:评估与治疗
J Neurol Surg B Skull Base. 2021 Feb;82(1):100-106. doi: 10.1055/s-0040-1722700. Epub 2021 Feb 18.